Publications by authors named "Michael Dukes"

Claim this Profile
D
Determinants of Landscape Irrigation Water Use in Florida-Friendly Yards.
Maria C Morera, Paul F Monaghan, Michael D Dukes

Environ Manage· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating nutrient impacts in urban watersheds: challenges and research opportunities.
Richard O Carey, George J Hochmuth, Christopher J Martinez, Treavor H Boyer, Michael D Dukes

Environ Pollut· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring of nitrate leaching in sandy soils: comparison of three methods.
Lincoln Zotarelli, Johannes M Scholberg, Michael D Dukes, Rafael Muñoz-Carpena

J Environ Qual· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer.
Stephen R Wedge, Jane Kendrew, Laurent F Hennequin, Paula J Valentine, Simon T Barry, Michael Dukes

Cancer Res· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic contrast-enhanced MRI of vascular changes induced by the VEGF-signalling inhibitor ZD4190 in human tumour xenografts.
David Checkley, Jean J L Tessier, Stephen R Wedge, Michael Dukes, Jane Kendrew

Magn Reson Imaging· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.
Stephen R Wedge, Donald J Ogilvie, Michael Dukes, Jane Kendrew, Rosemary Chester

Cancer Res· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 4-anilinoquinazolines with C-7 basic side chains: design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors.
Laurent F Hennequin, Elaine S E Stokes, Andrew P Thomas, Craig Johnstone, Patrick A Plé, Michael Dukes

J Med Chem· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis